Isolation and Structure Determination of a Sesquiterpene Lactone (vernodalinol) Fromvernonia Amygdalinaextracts

Xuan Luo,Yan Jiang,Frank R. Fronczek,Cuiwu Lin,Ernest B. Izevbigie,Ken S. Lee
DOI: https://doi.org/10.3109/13880209.2010.523429
2011-01-01
Pharmaceutical Biology
Abstract:Objective: A sesquiterpene lactone, vernodalinol, was isolated from VA leaves. The first reported source of vernodalinol was in 2009 from a different plant, only <SU1</SUH NMR spectrum and no detailed structural analysis were carried out. No whole spectroscopic data were provided.Materials and methods: VA dried leaves were extracted with 85% ethanol followed by further separation into four fractions by liquid--liquid extraction technique using various solvents: hexane, chloroform, and n-butanol. Vernodalinol was separated from the n-butanol fraction by column chromatography. The biological activity of vernodalinol was evaluated in estrogen receptor-positive (ER<SU++</SU) human breast carcinoma cells (MCF-7) in vitro.Results: Results indicated that vernodalinol (25 and 50 mu mu g/mL) inhibited breast cancerous cell growth (DNA synthesis) by 34% (P < 0.025) and 40% (P < 0.025), respectively. It is reasonable to expect an LC50 of 70--75 mu mu g/mL for vernodalinol in MCF-7 cells.Discussion and conclusion: Vernodalinol structure was confirmed using a battery of spectroscopic methods, 1D and 2D NMR, high-resolution mass spectrometry (HR-MS), UV, IR, and X-ray. These results suggest that vernodalinol, although it has some biological activity, is likely to work in concert with other ingredients responsible for the anticancer activity exhibited of VA.
What problem does this paper attempt to address?